Trials / Unknown
UnknownNCT02881502
Clinical Study of Relationship Between Granulocyte Activation, HDAC2 and Severe Asthma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Program: Clinical Study of Relationship Between Granulocyte Activation, HDAC2 and Severe Asthma Aim:The early prediction of severe asthma, early intervention on the disease, reduce the family and the national finance. design:This study is a single center randomized controlled trial designed by the Department of respiratory medicine, Xijing Hospital, as the main research unit.Compare the case group(severe asthma group and mild-and-moderate asthma group) and control group(healthy control group) by detecting the activity of MPO、NE、MMP-9 and ECP in the peripheral blood and the activity of HDAC2 in PBMCs of patients. case:60 Case selection: Inclusion criteria: age 18-75 years old; diagnosis of asthma was clear; informed consent was signed. Exclusion criteria: poor compliance; cognitive ability is low; psychiatric disorders need to be combined with psychotropic medication.
Detailed description
Application of SPSS 19 statistical software. Measurement data were expressed as mean ± standard deviation. First the data is normality tested and homogeneity of variance tested, according to the measurement data of normal distribution by SNK single factor analysis of variance; does not conform to the normal distribution of measurement data, using the Kruskal Wallis non parametric test. P \< 0.05 for the difference was statistically significant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | severe asthma group | No intervention |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-08-29
- Last updated
- 2016-08-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02881502. Inclusion in this directory is not an endorsement.